Phibro Animal Health Corporation PAHC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 10.10% | 17.12% | 25.98% | 32.39% | 33.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.10% | 17.12% | 25.98% | 32.39% | 33.71% |
| Cost of Revenue | 7.82% | 14.13% | 24.94% | 31.30% | 32.82% |
| Gross Profit | 14.95% | 23.58% | 28.16% | 34.71% | 35.66% |
| SG&A Expenses | 13.40% | 15.35% | 16.13% | 16.29% | 15.59% |
| Depreciation & Amortization | 1.22% | 1.22% | -20.46% | -20.46% | -20.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.07% | 14.39% | 22.69% | 27.42% | 28.34% |
| Operating Income | 17.72% | 39.85% | 54.38% | 81.31% | 93.92% |
| Income Before Tax | 47.78% | 102.00% | 154.88% | 273.59% | 191.07% |
| Income Tax Expenses | 38.47% | 90.71% | 79.18% | 135.90% | 77.54% |
| Earnings from Continuing Operations | 51.46% | 106.61% | 199.55% | 376.73% | 289.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.46% | 106.61% | 199.55% | 376.73% | 289.61% |
| EBIT | 17.72% | 39.85% | 54.38% | 81.31% | 93.92% |
| EBITDA | 15.03% | 33.40% | 45.83% | 67.88% | 77.65% |
| EPS Basic | 51.28% | 106.39% | 199.41% | 376.49% | 289.39% |
| Normalized Basic EPS | 22.04% | 39.30% | 72.48% | 153.31% | 141.04% |
| EPS Diluted | 50.84% | 106.09% | 200.48% | 375.10% | 290.50% |
| Normalized Diluted EPS | 21.51% | 38.50% | 71.59% | 152.16% | 139.96% |
| Average Basic Shares Outstanding | 0.13% | 0.12% | 0.06% | 0.05% | 0.03% |
| Average Diluted Shares Outstanding | 0.58% | 0.72% | 0.59% | 0.51% | 0.49% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.34% | -0.52% | -0.67% | -0.79% | -0.74% |